NGL FINECHEM
Back to Balance Sheet
|
NGL FINECHEM Last 5 Year Total Non-Current Assets History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Non-Current Assets | ₹143 Cr | ₹124 Cr | ₹103 Cr | ₹83 Cr | ₹73 Cr |
What is the latest Total Non-Current Assets ratio of NGL FINECHEM ?
Year | Total Non-Current Assets |
---|---|
Mar2024 | ₹143 Cr |
Mar2023 | ₹124 Cr |
Mar2022 | ₹103 Cr |
Mar2021 | ₹83 Cr |
Mar2020 | ₹73 Cr |
How is Total Non-Current Assets of NGL FINECHEM Trending?
Years | Total Non-Current Assets | % Change | |
---|---|---|---|
Mar2024 | ₹143 Cr | 14.83 | |
Mar2023 | ₹124 Cr | 20.29 | |
Mar2022 | ₹103 Cr | 24.83 | |
Mar2021 | ₹83 Cr | 13.88 | |
Mar2020 | ₹73 Cr | - |
Compare Total Non-Current Assets of peers of NGL FINECHEM
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NGL FINECHEM | ₹851.7 Cr | 5% | 37.2% | -48% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹406,267.0 Cr | 0.7% | 2.8% | 7.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹178,672.0 Cr | -0.8% | 3.7% | 48.6% | Stock Analytics | |
CIPLA | ₹119,713.0 Cr | -0.2% | -0.1% | -1.9% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹119,195.0 Cr | 3.4% | 11.2% | 17.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,999.0 Cr | 0.6% | -5.2% | -4.9% | Stock Analytics |
NGL FINECHEM Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NGL FINECHEM | 5% |
37.2% |
-48% |
SENSEX | -0.9% |
0.4% |
1.4% |
You may also like the below Video Courses